Article thumbnail

Brain-derived neurotrophic factor and schizophrenia

By Jessica L. Gören

Abstract

Schizophrenia is a severe disorder affecting approximately 1% of the population. Historically, alterations of dopaminergic function were considered the primary cause of schizophrenia. However, for many patients, drugs that alter dopaminergic function do not consistently lead to resolution of the symptoms of schizophrenia. Thus, there is an increased interest in pathophysiologic processes that result in altered neurodevelopment and plasticity associated with schizophrenia. Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neurogenesis, synaptic plasticity, cognition, and neurotransmission. Genetic polymorphism, expression, and function of BDNF have been implicated in psychiatric diseases, including schizophrenia. This review discusses BDNF, its role in neurologic processes, and the evidence implicating BDNF in schizophrenia

Topics: schizophrenia, brain-derived neurotrophic factor, BDNF
Publisher: 'College of Psychiatric and Neurologic Pharmacists (CPNP)'
Year: 2018
DOI identifier: 10.9740/mhc.2016.11.285.
OAI identifier: oai:dash.harvard.edu:1/37298411
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://nrs.harvard.edu/urn-3:H... (external link)
  • http://dx.doi.org/10.9740/mhc.... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.